Skip to main content
logo
Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
14.21
+0.14 (1.00%)
At close: Aug 11, 2026, 4:00 PM EDT
14.21
0.00 (0.00%)
After-hours: Aug 11, 2026, 4:10 PM EDT

Evommune Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Market Cap
516540--
Market Cap Growth
----
Enterprise Value
323.55392.0200
Last Close Price
14.2117.12--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
PS Ratio
51.5741.51--
PB Ratio
1.862.63--
P/TBV Ratio
1.170.51--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
EV/Sales Ratio
32.3530.16--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.020.0100.01
Net Debt / Equity Ratio
-0.70-0.720.501.00
Net Debt / EBITDA Ratio
1.921.851.042.11
Net Debt / FCF Ratio
2.591.931.232.59
Asset Turnover
0.040.090.090.06
Quick Ratio
11.488.332.5711.53
Current Ratio
11.688.572.6411.67
Return on Equity (ROE)
-39.19%-54.42%-112.09%-47.52%
Return on Assets (ROA)
-38.68%-53.87%-88.45%-46.02%
Return on Invested Capital (ROIC)
-119.42%-218.33%-2527.55%-1267.58%
Return on Capital Employed (ROCE)
-41.46%-63.56%-113.41%-50.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Buyback Yield / Dilution
-1390.45%-306.86%-20.35%-
Total Shareholder Return
-1390.45%-306.86%-20.35%-
SEC Filings: 10-K · 10-Q